Literature DB >> 23612822

[The role of the National Institute of Neoplastic Diseases in the control of cancer in Peru].

Miriam Rosario Salazar1, Roxana Regalado-Rafael, Jeannie Magalli Navarro, Dayana Melissa Montanez, Julio Elías Abugattas, Tatiana Vidaurre.   

Abstract

With a mortality rate that constitutes the second nationwide, the estimated incidence of cancer in Peru is 150 cases x 100 000 inhabitants. Around 75% of the cases are diagnosed at an advanced stage and mainly in Lima. In this context, the National Institute of Neoplastic Diseases (INEN) has promoted the decentralization of oncological care creating regional institutes of neoplastic diseases, oncological units and prevention centers. In addition, INEN has designed, developed and implemented the Budgetary Program for Cancer Prevention and Control, which, since 2011, has allowed for more than 7000 centers around the country to allocate resources to the prevention, promotion and early detection of the most frequent cancers in Peru. With the financial support of the state's health insurance system, the basic strategic central points were integrated to provide low-income cancer patients with comprehensive medical care. Through this way, and within the framework of a state policy integrated to and articulated with the health sector, the National Plan for Comprehensive Medical Care for Cancer Patients and the Improvement in the Access to Oncological Services in Peru, known as "The Hope Plan", was born. This article elaborates on the role that INEN plays in the control of cancer as a public health issue, highlighting the importance of the Strategic Budgetary Program for Cancer Prevention and Control and its role in the "The Hope Plan".

Entities:  

Mesh:

Year:  2013        PMID: 23612822     DOI: 10.1590/s1726-46342013000100020

Source DB:  PubMed          Journal:  Rev Peru Med Exp Salud Publica        ISSN: 1726-4634


  4 in total

1.  Building Oncofertility Core Competency in Developing Countries: Experience From Egypt, Tunisia, Brazil, Peru, and Panama.

Authors:  Mahmoud Salama; Lauren Ataman; Tamer Taha; Osama Azmy; Marouen Braham; Fatma Douik; Mohamed Khrouf; Jhenifer Kliemchen Rodrigues; Fernando M Reis; Flor Sánchez; Sergio Romero; Mario Vega; Teresa K Woodruff
Journal:  J Glob Oncol       Date:  2018-09

2.  Cancer-related mortality in Peru: Trends from 2003 to 2016.

Authors:  Jessica H Zafra-Tanaka; Janeth Tenorio-Mucha; David Villarreal-Zegarra; Rodrigo Carrillo-Larco; Antonio Bernabe-Ortiz
Journal:  PLoS One       Date:  2020-02-06       Impact factor: 3.240

3.  Building Oncofertility Core Competency in Developing Countries: Experience From Egypt, Tunisia, Brazil, Peru, and Panama.

Authors:  Mahmoud Salama; Lauren Ataman; Tamer Taha; Osama Azmy; Marouen Braham; Fatma Douik; Mohamed Khrouf; Jhenifer Kliemchen Rodrigues; Fernando M Reis; Flor Sánchez; Sergio Romero; Mario Vega; Teresa K Woodruff
Journal:  JCO Glob Oncol       Date:  2020-03-02

4.  The current situation regarding the availability and accessibility of anticancer drugs for breast cancer in the Peruvian public health systems.

Authors:  Guillermo Valencia-Mesías; Patricia Rioja-Viera; Zaida Morante-Cruz; Yura Toledo-Morote; Silvia Neciosup-Delgado; Henry Gómez-Moreno
Journal:  Ecancermedicalscience       Date:  2021-04-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.